Delivery Order SPE2DB22D2211-SPE2DB25FRRDN
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$9.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,685.20, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.57 firm fixed-price delivery order is for the supply of 4566661219 ENGERIX-B 20 MCG/ML SYRNML, with a completion date of December 10, 2024. This contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,399.12 firm fixed-price delivery order is for the pharmaceutical product ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The award has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the U.S. government. The contract has a ceiling value of $1,693.70 and an ultimate completion date of May 6, 2024. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a subdivision of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite...
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,106.02 and an ultimate completion date of January 19, 2024. This is a Delivery Order contract with a Firm Fixed Price pricing type, awarded on January 18, 2024. The contract is not designated with a set-aside...
The Defense Logistics Agency (DLA) awarded a $3,195.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML VIAL/ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,039.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 3, 2024, with a completion date of July 5, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as...
This federal contract award, valued at $87,117.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with a potential value of $2,473.93 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
This federal contract award, with the ID SPE2DX15D6028|SPE2DX25FWFSL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,807.26 firm fixed-price delivery order is for the medical product "ENGERIX-B 10MCG 10S" and has an ultimate completion date of December 4, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...